CuePath Innovation Closes USD$1.8M Oversubscribed Seed Round, Appoints Board

CuePath Innovation Inc. (“CuePath”, or the "Company") announced that the Company has closed its Seed Round, oversubscribed at USD$1.8M. This includes a concurrent investment from Genome BC's Industry Innovation Program (I2) Fund; seed funds E-Fund and Canada Innovation Acceleration Investment; and a group of technology, healthcare, and social impact Angel investors. CuePath is a healthcare [...]

November 10th, 2017|Uncategorized|

Genome BC Invests in CuePath

CuePath is proud to share an announcement from Genome BC which will help CuePath take it's game changing medication monitoring technology to the next level. Click here for details:

November 2nd, 2017|Uncategorized|